Literature DB >> 226960

Structure of the antithrombin-binding site in heparin.

U Lindahl, G Bäckström, M Höök, L Thunberg, L A Fransson, A Linker.   

Abstract

Heparin preparations from pig intestinal mucosa and from bovine lung were separated by chromatography on antithrombin-Sepharose into a high-affinity fraction (with high anticoagulant activity) and a low-affinity fraction (with low anticoagulant). Antithrombin-binding heparin fragments (12-16 monosaccharide units) were prepared, either by digesting a high-affinity heparin-antithrombin complex with bacterial heparinase or by partial deaminative cleavage of the unfractionated polysaccharide with nitrous acid followed by affinity chromatography on immobilized antithrombin. Compositional analysis based on separation and identification of deamination products reduced with sodium boro[3H]hydride showed that nonsulfated L-iduronic acid occurred in larger amounts in high-affinity heparin than in low-affinity heparin; furthermore, this component was concentrated in the antithrombin-binding regions of the high-affinity heparin molecules, amounting to approximately one residue per binding site. It is suggested that nonsulfated L-iduronic acid is essential for the anticoagulant activity of heparin. The location of the non-sulfated uronic acid in the antithrombin-binding site was determined by periodate oxidation of antithrombin-binding fragments containing a terminal 2,5-anhydro-D-[1-3H]mannitol unit. Tentative structures for antithrombin-binding sequences in heparin are proposed, including some structural variants believed to be compatible with, but not required for, activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 226960      PMCID: PMC383791          DOI: 10.1073/pnas.76.7.3198

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Biosynthesis of heparin. Assay and properties of the microsomal uronosyl C-5 epimerase.

Authors:  G Bäckström; M Höök; U Lindahl; D S Feingold; A Malmström; L Rodén; I Jacobsson
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

2.  THE ROLE OF SERINE IN THE LINKAGE OF HEPARIN TO PROTEIN.

Authors:  U LINDAHL; J A CIFONELLI; B LINDAHL; L RODEN
Journal:  J Biol Chem       Date:  1965-07       Impact factor: 5.157

3.  Relationship between anticoagulant activity of heparin and susceptibility to periodate oxidation.

Authors:  L A Fransson; W Lewis
Journal:  FEBS Lett       Date:  1979-01-01       Impact factor: 4.124

4.  Structure and biosynthesis of heparin-like polysaccharides.

Authors:  U Lindahl; M Höök; G Bäckström; I Jacobsson; J Riesenfeld; A Malmström; L Rodén; D S Feingold
Journal:  Fed Proc       Date:  1977-01

5.  Human kidney alpha-L-iduronidase: purification and characterization.

Authors:  L H Rome; A J Garvin; E F Neufeld
Journal:  Arch Biochem Biophys       Date:  1978-08       Impact factor: 4.013

6.  Formation of anhydrosugars in the chemical depolymerization of heparin.

Authors:  J E Shively; H E Conrad
Journal:  Biochemistry       Date:  1976-09-07       Impact factor: 3.162

Review 7.  Chemistry of the hemostatic mechanism and its relationship to the action of heparin.

Authors:  R D Rosenberg
Journal:  Fed Proc       Date:  1977-01

8.  The molecular-weight-dependence of the anti-coagulant activity of heparin.

Authors:  T C Laurent; A Tengblad; L Thunberg; M Höök; U Lindahl
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

9.  Identification of N-sulphated disaccharide units in heparin-like polysaccharides.

Authors:  I Jacobsson; M Höök; I Pettersson; U Lindahl; O Larm; E Wirén; K von Figura
Journal:  Biochem J       Date:  1979-04-01       Impact factor: 3.857

10.  Structure-function relationships of heparin species.

Authors:  R D Rosenberg; G Armand; L Lam
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

View more
  65 in total

1.  Insights into the role of 3-O-sulfotransferase in heparan sulfate biosynthesis.

Authors:  Maria Cecília Zorél Meneghetti; Tarsis Gesteira Ferreira; Alexandre Keiji Tashima; Suely F Chavante; Edwin Alexander Yates; Jian Liu; Helena Bonciani Nader; Marcelo A Lima
Journal:  Org Biomol Chem       Date:  2017-08-16       Impact factor: 3.876

Review 2.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

3.  The C-terminal fragment of axon guidance molecule Slit3 binds heparin and neutralizes heparin's anticoagulant activity.

Authors:  Eduard Condac; Heather Strachan; Gerardo Gutierrez-Sanchez; Benjamin Brainard; Christina Giese; Christian Heiss; Darryl Johnson; Parastoo Azadi; Carl Bergmann; Ron Orlando; Charles T Esmon; Job Harenberg; Kelley Moremen; Lianchun Wang
Journal:  Glycobiology       Date:  2012-05-28       Impact factor: 4.313

4.  Filter-entrapment enrichment pull-down assay for glycosaminoglycan structural characterization and protein interaction.

Authors:  Yanlei Yu; Fuming Zhang; Gina Renois-Predelus; I Jonathan Amster; Robert J Linhardt
Journal:  Carbohydr Polym       Date:  2020-06-10       Impact factor: 9.381

Review 5.  Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development.

Authors:  Daniel Radke; Wenkai Jia; Dhavan Sharma; Kemin Fena; Guifang Wang; Jeremy Goldman; Feng Zhao
Journal:  Adv Healthc Mater       Date:  2018-05-07       Impact factor: 9.933

Review 6.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

7.  Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.

Authors:  P Andrade-Gordon; S Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

8.  Arginine residues are critical for the heparin-cofactor activity of antithrombin III.

Authors:  A M Jorgensen; C L Borders; W W Fish
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

9.  Characterizing the microstructure of heparin and heparan sulfate using N-sulfoglucosamine 1H and 15N NMR chemical shift analysis.

Authors:  Derek J Langeslay; Consuelo N Beecher; Annamaria Naggi; Marco Guerrini; Giangiacomo Torri; Cynthia K Larive
Journal:  Anal Chem       Date:  2012-12-31       Impact factor: 6.986

10.  Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.

Authors:  Sophie M Thompson; David G Fernig; Edwin C Jesudason; Paul D Losty; Els M A van de Westerlo; Toin H van Kuppevelt; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.